Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Ingemarsson-Matzen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.0% 1.4% 1.3% 1.1% 2.1% 2.2% 13.0% 13.0%   Credit score (0-100)   59 79 80 82 67 65 18 18   Credit rating   BBB A A A A BBB BB BB   Credit limit (kDKK)   0.0 15.3 48.1 128.2 0.2 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,617 1,662 1,820 2,523 1,955 2,412 0.0 0.0   EBITDA   2.6 401 605 588 -13.8 19.6 0.0 0.0   EBIT   -22.8 378 570 508 -113 -44.2 0.0 0.0   Pre-tax profit (PTP)   -103.0 345.1 533.6 500.1 -175.1 -52.4 0.0 0.0   Net earnings   156.9 269.2 420.1 382.2 -141.2 -40.9 0.0 0.0   Pre-tax profit without non-rec. items   -103 345 534 500 -175 -52.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,051 2,027 2,043 2,312 2,301 2,210 0.0 0.0   Shareholders equity total   1,566 1,835 2,255 2,638 2,382 2,223 535 535   Interest-bearing liabilities   590 547 488 406 416 406 0.0 0.0   Balance sheet total (assets)   2,542 2,648 3,496 3,939 3,087 3,065 535 535   Net Debt   249 105 -706 -880 -68.6 -89.4 -535 -535     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,617 1,662 1,820 2,523 1,955 2,412 0.0 0.0   Gross profit growth   -2.2% 2.7% 9.5% 38.6% -22.5% 23.4% -100.0% 0.0%   Employees   4 4 0 0 0 5 0 0   Employee growth %   -20.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,542 2,648 3,496 3,939 3,087 3,065 535 535   Balance sheet change%   -5.9% 4.2% 32.0% 12.7% -21.6% -0.7% -82.5% 0.0%   Added value   2.6 401.3 604.9 588.0 -32.6 19.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -51 -47 -19 189 -110 -155 -841 -1,369   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1.4% 22.7% 31.3% 20.1% -5.8% -1.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -0.5% 14.8% 18.8% 14.4% -3.2% -0.8% 0.0% 0.0%   ROI %   -0.6% 16.1% 21.2% 17.4% -3.7% -0.8% 0.0% 0.0%   ROE %   10.5% 15.8% 20.5% 15.6% -5.6% -1.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   61.8% 69.6% 65.7% 67.9% 77.3% 74.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   9,484.6% 26.2% -116.8% -149.7% 496.2% -456.3% 0.0% 0.0%   Gearing %   37.7% 29.8% 21.6% 15.4% 17.5% 18.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.6% 6.7% 8.4% 7.5% 15.1% 7.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 3.1 2.4 2.2 2.9 2.0 0.0 0.0   Current Ratio   1.3 3.5 2.3 2.2 3.3 1.9 0.0 0.0   Cash and cash equivalent   341.4 442.0 1,194.3 1,286.5 484.8 495.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -141.1 165.4 549.1 598.4 289.4 140.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1 100 0 0 0 4 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 100 0 0 0 4 0 0   EBIT / employee   -6 94 0 0 0 -9 0 0   Net earnings / employee   39 67 0 0 0 -8 0 0